Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease
Jeremy F. Strain,
Matthew R. Brier,
Aaron Tanenbaum,
Brian A. Gordon,
John E. McCarthy,
Aylin Dincer,
Daniel S. Marcus,
Jasmeer P. Chhatwal,
Neill R. Graff-Radford,
Gregory S. Day,
Christian la Fougère,
Richard J. Perrin,
Stephen Salloway,
Peter R. Schofield,
Igor Yakushev,
Takeshi Ikeuchi,
Jonathan Vöglein,
John C. Morris,
Tammie L.S. Benzinger,
Randall J. Bateman,
Beau M. Ances,
Abraham Z. Snyder
Affiliations
Jeremy F. Strain
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA
Matthew R. Brier
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA
Aaron Tanenbaum
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA
Brian A. Gordon
Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA; Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Psychological & Brain Sciences, Washington University, St. Louis, MO, USA
John E. McCarthy
Department of Mathematics and Statistics, Washington University, St. Louis, MO 63130, USA
Aylin Dincer
Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA
Daniel S. Marcus
Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA; Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA
Jasmeer P. Chhatwal
Martinos Center, Massachusetts General Hospital, 149 13th St Room 2662, Charlestown, MA 02129, USA
Neill R. Graff-Radford
Department of Neurology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, Fl 32224, USA
Gregory S. Day
Department of Neurology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, Fl 32224, USA
Christian la Fougère
Department of Nuclear Medicine and Clinical Molecular Imaging, Universityhospital Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen, Germany
Richard J. Perrin
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA; Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA
Stephen Salloway
Alpert Medical School of Brown University, 345 Blackstone Boulevard, Providence, RI 02906, USA
Peter R. Schofield
Neuroscience Research Australia, Sydney, NSW 2131, Australia; School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia
Igor Yakushev
Department of Nuclear Medicine, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, Munich 81675, Germany
Takeshi Ikeuchi
Department of Molecular Genetics, Brain Research Institute, Niigata University, Japan
Jonathan Vöglein
Department of Neurology, Ludwig-Maximilians-Universität Munich, Germany
John C. Morris
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA; Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA
Tammie L.S. Benzinger
Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA; Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA
Randall J. Bateman
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA; Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO 63110, USA
Beau M. Ances
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA; Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO 63110, USA
Abraham Z. Snyder
Department of Neurology, Washington University in Saint Louis, St. Louis, MO 63110, USA; Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA; Corresponding author at: Department of Radiology, Washington University in Saint Louis, Box 8225, 660 South Euclid Ave, St. Louis, MO 63110, USA.
Prior studies of aging and Alzheimer disease have evaluated resting state functional connectivity (FC) using either seed-based correlation (SBC) or independent component analysis (ICA), with a focus on particular functional systems. SBC and ICA both are insensitive to differences in signal amplitude. At the same time, accumulating evidence indicates that the amplitude of spontaneous BOLD signal fluctuations is physiologically meaningful. We systematically compared covariance-based FC, which is sensitive to amplitude, vs. correlation-based FC, which is not, in affected individuals and controls drawn from two cohorts of participants including autosomal dominant Alzheimer disease (ADAD), late onset Alzheimer disease (LOAD), and age-matched controls. Functional connectivity was computed over 222 regions of interest and group differences were evaluated in terms of components projected onto a space of lower dimension. Our principal observations are: (1) Aging is associated with global loss of resting state fMRI signal amplitude that is approximately uniform across resting state networks. (2) Thus, covariance FC measures decrease with age whereas correlation FC is relatively preserved in healthy aging. (3) In contrast, symptomatic ADAD and LOAD both lead to loss of spontaneous activity amplitude as well as severely degraded correlation structure. These results demonstrate a double dissociation between age vs. Alzheimer disease and the amplitude vs. correlation structure of resting state BOLD signals. Modeling results suggest that the AD-associated loss of correlation structure is attributable to a relative increase in the fraction of locally restricted as opposed to widely shared variance.